Intervention

Sham Injection

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma PatientsNCT02396316 · 2015-04-02

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human HyaluronidaseNCT01526733 · 2011-12-01

Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular EdemaNCT00309192 · 2006-04-01

Common conditions

Diabetes Mellitus1 Glaucoma, Neovascular1 Macular Edema1 Type 1 Diabetes Mellitus1

Leading sponsors

Bayer1 Halozyme Therapeutics1 Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA1

Trial status mix

COMPLETED3

Phase mix

PHASE32

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.